Ruppiner Kliniken

Neuruppin 16816

2 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Metabolic Dysfunction-Associated Steatotic Liver Disease

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer — Recruiting now